Emerging Role of Acitretin in Cutaneous Squamous Cell Carcinoma: From Prevention to Treatment
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/7110982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 20.04.2026. Verfasst von Fujin Zhou und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers worldwide, with an increasing incidence that poses a significant public health challenge. Acitretin, a synthetic retinoid clinically used to treat epidermal hyperproliferative disorders, has emerged as a promising therapy for cSCC. This review summarizes current evidence on its efficacy, safety, dosing strategies, discontinuation‐related issues, combination regimens, and underlying mechanisms in cSCC. Available data support its chemopreventive role mainly in immunocompromised patients, whereas evidence in immunocompetent patients remains limited. Dosing regimens vary, and adverse effects include teratogenicity and cutaneous and mucosal toxicity. In some cases, rebound increases in keratinocyte carcinomas have been observed after treatment discontinuation. Combination therapy with photodynamic therapy (PDT) or 5‐fluorouracil (5‐FU) has shown promise in refractory cases. Mechanistically, we emphasize the pivotal role of the cellular retinoic acid‐binding protein II (CRABP‐II) pathway in mediating acitretin’s antitumor effects, along with a range of other pertinent mechanisms. Further research should optimize treatment strategies of acitretin and fully elucidate its therapeutic mechanisms, with the ultimate goal of improving the clinical outcomes of cSCC patients.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
Zitieren
APA
Zhou, F., Kang, Z., Li, Z., Yan, G., & Zhang, G. (2026). Emerging Role of Acitretin in Cutaneous Squamous Cell Carcinoma: From Prevention to Treatment. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/7110982
Vancouver
Zhou F, Kang Z, Li Z, Yan G, Zhang G. Emerging Role of Acitretin in Cutaneous Squamous Cell Carcinoma: From Prevention to Treatment. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/7110982
BibTeX
@article{Zhou2026,
author = {Zhou, Fujin and Kang, Ziwei and Li, Zhenlin and Yan, Guorong and Zhang, Guolong},
title = {Emerging Role of Acitretin in Cutaneous Squamous Cell Carcinoma: From Prevention to Treatment},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/7110982}
}
EUVIMED